| 标题 |
Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Journal of Pharmacology 作者:Jie Mao; Hongbao Yang; Tingting Cui; Pan Pan; Nadia Kabir; et al 出版日期:2018-05-18 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)